H.R. 4709

Status: In committee

Newborn Screening Saves Lives Reauthorization Act of 2025

Sponsored by Kelly Morrison (Democrat-MN-3)

Topics

Cosponsors

Actions

Roll calls

Amendments

Related bills

Actions

Sep 10, 2025 · House committee actions

Referred to the Subcommittee on Health.

Sep 10, 2025 · House committee actions

Subcommittee Consideration and Mark-up Session Held

Sep 10, 2025 · House committee actions

Forwarded by Subcommittee to Full Committee by Voice Vote.

Jul 23, 2025 · Library of Congress

Introduced in House

Jul 23, 2025 · Library of Congress

Introduced in House

Jul 23, 2025 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

July 2026

Lobbying reported · American Academy of Pediatrics · Jul 22

American Academy of Pediatrics reported 2nd Quarter (Apr 1 - June 30) lobbying for American Academy of Pediatrics — $789,257

Lobbying reported · Mason Consulting · Jul 22

Mason Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Pediatric Nurse Practitioners — $24,000

BillsH.J.Res. 189 H.R. 247 H.R. 392 H.R. 498 H.R. 929 H.R. 1061 H.R. 1197 H.R. 1317 H.R. 1435 H.R. 1582 H.R. 1616 H.R. 1735 H.R. 2172 H.R. 2234 H.R. 2319 H.R. 2332 H.R. 2472 H.R. 2493 H.R. 2531 H.R. 2586 H.R. 3108 H.R. 3145 H.R. 3170 H.R. 3333 H.R. 3492 H.R. 3514 H.R. 3593 H.R. 3624 H.R. 3684 H.R. 3701 H.R. 3884 H.R. 4122 H.R. 4206 H.R. 4619 H.R. 4709 H.R. 4725 H.R. 4773 H.R. 4849 H.R. 5081 H.R. 5145 H.R. 5199 H.R. 5217 H.R. 5434 H.R. 5448 H.R. 5469 H.R. 5582 H.R. 6088 H.R. 6199 H.R. 6203 H.R. 6252 H.R. 6394 H.R. 6396 H.R. 6409 H.R. 6484 H.R. 6561 H.R. 6574 H.R. 6607 H.R. 6677 H.R. 6703 H.R. 6718 H.R. 6739 H.R. 6845 H.R. 6862 H.R. 6894 H.R. 6945 H.R. 6987 H.R. 7092 H.R. 7106 H.R. 7147 H.R. 7279 H.R. 7324 H.R. 7567 H.R. 7757 H.R. 7787 H.R. 7867 H.R. 7875 H.R. 7973 H.R. 8081 H.R. 8089 H.R. 8107 H.R. 8163 H.R. 8201 H.R. 8209 H.R. 8312 H.R. 8385 H.R. 8425 H.R. 8429 H.R. 8464 H.R. 8521 H.R. 8646 H.R. 8657 H.R. 8691 H.R. 8800 H.R. 8872 H.R. 9022 H.R. 9257 H.R. 9260 H.R. 9393 S. 222 S. 266 S. 272 S. 278 S. 455 S. 575 S. 683 S. 717 S. 836 S. 891 S. 921 S. 1058 S. 1157 S. 1232 S. 1261 S. 1482 S. 1562 S. 1599 S. 1748 S. 1805 S. 1816 S. 1874 S. 1885 S. 1924 S. 2167 S. 2169 S. 2556 S. 2709 S. 2826 S. 2857 S. 2858 S. 2954 S. 3199 S. 3296 S. 3315 S. 3329 S. 3350 S. 3386 S. 3435 S. 3569 S. 3602 S. 3707 S. 3714 S. 3799 S. 3836 S. 3853 S. 3934 S. 4110 S. 4141 S. 4186 S. 4189 S. 4202 S. 4242 S. 4387 S. 4568 S. 4754 S.Con.Res. 33 S.J.Res. 196

Lobbying reported · Stealth Biotherapeutics · Jul 20

Stealth Biotherapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Stealth Biotherapeutics — $120,000

BillsH.R. 1262 H.R. 4121 H.R. 4709 H.R. 6280 S. 932 S. 2256 S. 3607

Lobbying reported · King & Spalding · Jul 20

King & Spalding reported 2nd Quarter (Apr 1 - June 30) lobbying for American College Of Medical Genetics — $20,000

BillsH.R. 4709 H.R. 7118

Lobbying reported · Travere Therapeutics · Jul 20

Travere Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Travere Therapeutics — $140,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1518 H.R. 4709 H.R. 9102 S. 932 S. 1040 S. 2658

Lobbying reported · Red+blue Strategies · Jul 17

Red+blue Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for GeneDx — $80,000

BillsH.R. 4709 H.R. 5269 H.R. 7118 S. 2761

Lobbying reported · The Nemours Foundation - A Florida Not-For-Profit · Jul 17

The Nemours Foundation - A Florida Not-For-Profit reported 2nd Quarter (Apr 1 - June 30) lobbying for Nemours Foundation - A Florida Not-For-Profit — $140,000

BillsH.R. 1404 H.R. 3762 H.R. 4709 H.R. 4768 H.R. 5469 H.R. 5582 H.R. 6238 H.R. 7118 H.R. 8317 H.R. 9260 H.R. 9390 H.R. 9504 S. 2355 S. 2448 S. 2858 S. 3254

Lobbying reported · EveryLife Foundation for Rare Diseases · Jul 17

EveryLife Foundation for Rare Diseases reported 2nd Quarter (Apr 1 - June 30) lobbying for EveryLife Foundation for Rare Diseases — $40,000

BillsH.R. 1414 H.R. 4709 H.R. 5509 H.R. 7118 S. 2903

Lobbying reported · Gridiron Public Affairs · Jul 17

Gridiron Public Affairs reported 2nd Quarter (Apr 1 - June 30) lobbying for Beren Therapeutics

BillsH.R. 4709 H.R. 7118

Lobbying reported · Revvity · Jul 13

Revvity reported 2nd Quarter (Apr 1 - June 30) lobbying for Revvity — $40,000

BillsH.R. 4709 S. 4612

You’re all caught up.